Leila Janani
Imperial College London, Iran University of Medical Sciences, Sharif University of Technology, Tehran University of Medical Sciences, Tabriz University
0000-0003-3829-6364
About
Leila is an Advanced Research Fellow and Senior Clinical Trials Statistician at the Imperial Clinical Trials Unit (ICTU), where she is Deputy Head of the Trials Methodology team (StatsCI). She joined ICTU in January 2021 and has over 14 years’ experience in teaching and in the design, conduct, monitoring, analysis and reporting of clinical trials. She holds a BSc in Statistics (Tabriz University) and an MSc and PhD in Biostatistics (Tehran University of Medical Sciences), and has also completed an MBA in Health certificate programme at Sharif University of Technology. Her methodological interests include efficient and robust trial design and the use of Bayesian approaches in trial design, particularly in critical care. She currently holds an NIHR Development and Skills Enhancement (DSE) Award in critical care trial methodology and is an active member of the NIHR Statistics Group – Improving Statistical Literacy, which aims to enhance the communication of statistics and improve statistical literacy through the NIHR network and infrastructure.
www.imperial.ac.uk/people/l.janani
Employment
-
Imperial College London Deputy Head of Trial Methodology / Advanced Research Fellow2024 - Present
-
Imperial College London Deputy Head of Trial Methdology /Research Fellow2023 - 2024
-
Imperial College London Research Fellow / Senior Clinical Trials Statistician2021 - 2023
-
Iran University of Medical Sciences Associate Professor of Biostatistics2020 - 2021
-
Iran University of Medical Sciences Assistant Professor of Biostatistics2015 - 2020
Education
-
Sharif University of Technology MBA certificate program2019 - 2021
-
Tehran University of Medical Sciences PhD in Biostatistics2010 - 2015
-
Tehran University of Medical Sciences MSc in Biostatistics2007 - 2010
-
Tabriz University BSc in Statistics2002 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (100)
- Optimising lipid-lowering therapy for acute coronary syndrome using a decision support system: insights from a cluster randomised trial Save
- Protocol for a group-sequential two-stratum multicenter open-label randomized clinical trial of respiratory support in infants with acute bronchiolitis: breathing assistance in children with bronchiolitis (BACHb) Save
- Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: results from COV-BOOST trial Save
- Evaluation of Emerging Antimicrobials Resistance in Nosocomial Infections Caused by E. coli : The Comparison Results of Observed Cases and Compartmental Model Save
- Past, present, and future of Phase 3 vaccine trial design: rethinking statistics for the 21st century. Save
- Optimizing cardiovascular disease mortality prediction: a super learner approach in the tehran lipid and glucose study. Save
- Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials. Save
- Mortality and re-fracture rates in low trauma hip fracture. Save
- Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial. Save
- Development and psychometric properties of the middle-age preparation scale for healthy aging (MPHA) Save